SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-010123
Filing Date
2019-08-06
Accepted
2019-08-06 16:06:00
Documents
7
Period of Report
2019-08-06
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K q219_epr-8k.htm 8-K 32935
2 EXHIBIT 99.1 a20190806q22019eprfinal.htm EX-99.1 19218
3 a20190806q22019eprfinal001.jpg GRAPHIC 197182
4 a20190806q22019eprfinal002.jpg GRAPHIC 211812
5 a20190806q22019eprfinal003.jpg GRAPHIC 210650
6 a20190806q22019eprfinal004.jpg GRAPHIC 267555
7 a20190806q22019eprfinal005.jpg GRAPHIC 98091
  Complete submission text file 0001628280-19-010123.txt   1410723
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37833 | Film No.: 191002080
SIC: 2836 Biological Products, (No Diagnostic Substances)